Predictive Oncology Alpha and Beta Analysis

POAIDelisted Stock  USD 5.95  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Predictive Oncology. It also helps investors analyze the systematic and unsystematic risks associated with investing in Predictive Oncology over a specified time horizon. Remember, high Predictive Oncology's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Predictive Oncology's market risk premium analysis include:
Beta
0.0164
Alpha
(0.82)
Risk
7.55
Sharpe Ratio
(0.12)
Expected Return
(0.92)
Please note that although Predictive Oncology alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Predictive Oncology did 0.82  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Predictive Oncology stock's relative risk over its benchmark. Predictive Oncology has a beta of 0.02  . As returns on the market increase, Predictive Oncology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Predictive Oncology is expected to be smaller as well. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Predictive Oncology Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Predictive Oncology market risk premium is the additional return an investor will receive from holding Predictive Oncology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Predictive Oncology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Predictive Oncology's performance over market.
α-0.82   β0.02

Predictive Oncology Fundamentals Vs Peers

Comparing Predictive Oncology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Predictive Oncology's direct or indirect competition across all of the common fundamentals between Predictive Oncology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Predictive Oncology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Predictive Oncology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Predictive Oncology by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Predictive Oncology to competition
FundamentalsPredictive OncologyPeer Average
Return On Equity-7.46-0.31
Return On Asset-1.29-0.14
Operating Margin(906.54) %(5.51) %
Current Valuation21.66 M16.62 B
Shares Outstanding3.39 M571.82 M
Shares Owned By Insiders4.92 %10.09 %
Shares Owned By Institutions0.15 %39.21 %

Predictive Oncology Opportunities

Predictive Oncology Return and Market Media

The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Penny stock jumps 200 percent on thrilling crypto announcement
09/29/2025
2
Will Predictive Oncology Inc. stock maintain strong growth - Portfolio Profit Report Low Risk Entry Point Guides - nchmf.gov.vn
10/20/2025
3
Predictive Oncology Updates ATM Offering Program - TipRanks
10/29/2025
4
Why retail investors pile into Predictive Oncology Inc. stock - Market Movers Consistent Income Trade Recommendations - fcp.pa.gov.br
11/06/2025
5
Is Predictive Oncology Inc. stock worth buying before Fed action - Quarterly Profit Review Consistent Profit Trading Strategies - newser.com
11/12/2025
6
Will Predictive Oncology Inc. stock test record highs in 2025 - Bond Market Risk Controlled Swing Trade Alerts - newser.com
11/19/2025
7
Predictive Oncology Stockholders Approve Key Proposals - TipRanks
11/25/2025
8
Predictive Oncology Regains Compliance with Nasdaqs Minimum Stockholders Equity Requirement
12/02/2025

About Predictive Oncology Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Predictive or other delisted stocks. Alpha measures the amount that position in Predictive Oncology has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Predictive Oncology Upcoming Company Events

As portrayed in its financial statements, the presentation of Predictive Oncology's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Predictive Oncology's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Predictive Oncology's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Predictive Oncology. Please utilize our Beneish M Score to check the likelihood of Predictive Oncology's management manipulating its earnings.
19th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Build Portfolio with Predictive Oncology

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in Predictive Stock

If you are still planning to invest in Predictive Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Predictive Oncology's history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like